Merck & Co., Inc. - Company & Market Research Reports

Home /
Companies /
Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 334
Infectious Diseases Drugs 245
Vaccines 240
Animal Healthcare/Veterinary 191
Endocrine and Metabolic Disorders Drugs 175
Immune Disorders Drugs 154
Animal Pharmaceuticals 135
Central Nervous System Drugs 133
Women's Health 132
Cardiovascular Drugs 126
Pharmaceuticals 112
Musculoskeletal Disorders Drugs 103
Drug Discovery 98
Biopharmaceuticals 95
Respiratory Drugs 81
Oncology 74
Clinical Trials 72
Allergy and Immunology 71
Sexual and Reproductive Health Drugs 71
Liver and Kidney Disorders Drugs 69
Diabetes Drugs 67
Antibiotics 62
Gastrointestinal Drugs 61
Biotechnology 60
Drug Delivery 59
Enzymes 57
Genomics 48
Analgesics 43
Optical Disorders Drugs 42
Dermatological Drugs 42
Brain Cancer Drugs 41
Skin Cancer Drugs 39
Infusions and Injectables 36
Diagnostics 36
Lymphoma Drugs 35
Pulmonary Medicine 34
Cancer Vaccines 33
Pharmaceutical Intermediates 32
Hematological Drugs 32
Biosimilars and Biosuperiors 32
Lung Cancer Drugs 30
Urological Disorders Drugs 29
Optical 28
HIV/AIDS Drugs 28
Pharmaceutical Manufacturing 28
Liver Cancer Drugs 26
Healthcare Services 25
Over the Counter (OTC) Drugs 25
Immunosuppressive Drugs 24
Neurology 23
Prostate Cancer Drugs 23
Infectious Disease Testing 23
Cervical Cancer Drugs 22
Allergy Drugs 22
Breast Cancer Drugs 21
Leukemia Drugs 21
Cardiology 21
Mental Disorders Drugs 19
Psoriasis Drugs 19
Asthma Drugs 18
Colon Cancer Drugs 17
Vitamins and Dietary Supplements 17
Drugs by Therapeutic Area 16
Inhalers and Nebulisers 16
Dermatology 16
E-Healthcare 15
Bladder Cancer Drugs 15
Medical Devices 15
Biomarkers 15
Gastroenterology 14
Fertility Services 13
Ovarian Cancer Drugs 13
Hematology 13
Pancreatic Cancer Drugs 13
Pediatrics 13
Alzheimer's Disease Drugs 13
Urology and Nephrology 12
Nanomedicine 12
Therapeutic Area 11
Generic Drugs 11
Transdermal and Transmucosal Drug Delivery 11
Kidney Cancer Drugs 11
Anti-Obesity Drugs 11
Respiratory Devices 10
Thyroid Cancer Drugs 10
In Vitro Diagnostics 9
Anesthetic Drugs 8
Mental Health 8
Uterine Cancer Drugs 7
Bronchitis Drugs 7
Proteomics 6
Healthcare 6
Other Healthcare Facilities 6
Laboratory Equipment 6
Endocrinology 6
Company Reports 5
Hepatology 5
Needles and Syringes 5
Cough and Cold Drugs 4
Surgical Procedures 4
Cardiovascular Devices 3
Diabetes Devices 3
Hospital Management 3
Molecular Diagnostics 3
Palliative Care 3
Acne Drugs 3
Anxiety Drugs 3
Schizophrenia Drugs 3
Addiction Disorders Drugs 2
Patient Monitoring Equipment 2
Pharmacoeconomics 2
Laboratory Testing 2
Dental 2
Mammography 2
Stem Cells 2
Blood Banking 2
Biomaterials 2
ENT Devices 2
Nursing 2
Surgical Devices 2
Endoscopy 2
Clinical Skills 2
Maternal and Neonatal Care 2
Orthopedic Devices 1
Dialysis 1
Cholesterol Testing 1
Managed Care 1
Neurology Devices 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Anatomy 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

3,382 Results (Page 56 of 170)
- Relevance
  Sort by

Specialty Pharmaceuticals Market 2026-2030

 Report
August 2026
308 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Companion Animal Specialty Drugs Market 2025-2029

 Report
March 2025
237 Pages
Global

From

€2237EUR$2,500USD£1,913GBP

Basal Cell Carcinoma Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-28)

 Report
April 2023
111 Pages
Global

From

€4250EUR$4,750USD£3,635GBP

Pet Vaccine Market - Forecasts from 2025 to 2030

 Report
August 2025
149 Pages
Global

From

€3534EUR$3,950USD£3,022GBP

Animal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
November 2025
180 Pages
Global

From

€4026EUR$4,500USD£3,443GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immune Checkpoint Inhibitors - Global Strategic Business Report

 Report
August 2026
190 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Metastatic Bone Disease - Global Strategic Business Report

 Report
August 2026
237 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Immunotherapy Drugs - Global Strategic Business Report

 Report
August 2026
193 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Hedgehog Pathway Inhibitors Market - Global Strategic Business Report

 Report
August 2026
102 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Oral Cancer Treatment - Global Strategic Business Report

 Report
August 2026
279 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Neuroendocrine Tumors Therapeutics - Global Strategic Business Report

 Report
August 2026
171 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors - Global Strategic Business Report

 Report
August 2026
275 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Epithelioma Treatment - Global Strategic Business Report

 Report
August 2026
380 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Esophageal Cancer Drugs - Global Strategic Business Report

 Report
August 2026
269 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Adrenocortical Carcinoma Treatment - Global Strategic Business Report

 Report
August 2026
289 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Myeloproliferative Disorders Drugs - Global Strategic Business Report

 Report
August 2026
172 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Tumor Necrosis Factor Inhibitor Drugs Market - Global Strategic Business Report

 Report
August 2026
291 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Cytotoxic Drugs - Global Strategic Business Report

 Report
August 2026
462 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Cancer Biological Therapy - Global Strategic Business Report

 Report
August 2026
211 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

Retinoblastoma Treatment Market - Global Strategic Business Report

 Report
August 2026
279 Pages
Global

From

€5234EUR$5,850USD£4,476GBP

3,382 Results (Page 56 of 170)
- 1
- 54
- 55
- 56
- 57
- 58

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.